Preclinical Safety Evaluation and First-in-Human Translational Study of [177Lu]Lu-TEFAPI-06
Clinical trial NCT07299253 · COMPLETED
Trial details
- NCT number
- NCT07299253
- Sponsor
- Lanzhou University Second Hospital
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-16
- Primary completion
- 2024-08-16
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.